Search
for
Sort by
Research 271–300 of 1000+
- Herbal Oil Formulation for Managing Male Pattern Baldness (Alopecia)
- Herbal Oil Formulation for Managing Male Pattern Baldness (Alopecia)
- Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies
- Biochemical features of primary cells from a pediatric patient with a gain-of-function <i>ODC1</i> genetic mutation
- Case of alopecia induced by sorafenib, possible mechanism similar to alopecia areata
- Trichotillomania in long COVID successfully treated with escitalopram: A case report
- Epidermal γδ T cells, CD8 T cells and macrophages are increased in number in alopecia areata and express BST2 as part of an interferon-driven antiviral gene signature
- Efficacy of Barictinib As Compared to Conventional Therapy as a Treatment for Alopecia Areata
- First drug for severe alopecia recommended by NICE could benefit 14,000 patients
- Efficacy and safety of baricitinib in patients with alopecia areata: evidence to date
- 034 Characterization of novel TMEM173 mutation causing a lupus- and SAVI-like phenotype, modified by polymorphisms in TMEM173 and IFIH1
- Experiences with Smo antagonist vismodegib for the treatment of locally advanced basal cell carcinoma
- Alleviation of alopecia after switching from escitalopram to duloxetine: a case report
- Clinical Snippets
- Dutasteride for Androgenetic Alopecia: Review Article
- The itchy scalp - scratching for an explanation
- 602 mTORC1 activity controls human scalp hair follicle pigmentation and growth
- 1458 EMT-inhibiting transcription factor Ovol2 regulates directional cell migration and proliferation in adult skin epithelia
- Tofacitinib therapy for children with severe alopecia areata
- Response to tofacitinib therapy of eyebrows and eyelashes in alopecia areata
- Advances in the treatment of male androgenetic alopecia: a brief review of finasteride studies.
- Successful treatment of refractory folliculitis decalvans with secukinumab
- Alopecia Areata in Skin of Color Patients: New Considerations Sparked by the Approval of Baricitinib
- P64 Efficacy of baricitinib in patients with different degrees of severe alopecia areata: 52-week results from BRAVE-AA1 and BRAVE-AA2
- 314 Molecular genetic dissection of ILVEN leads to successful targeted therapy
- 688 Efficacy of topical Vorinostat in the reversal of alopecia areata
- Bone Morphogenetic Protein Signaling Regulates Postnatal Hair Follicle Differentiation and Cycling
- Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study
- New Treatment Options for Alopecia Areata
- 033 IL-15 is an unexpected guardian of hair follicle immune privilege and promotes human hair growth ex vivo